InterMune

• NCT00786643

  Collaborator, Phase 2, Completed, 48 people, Nov 6, 2008

• NCT00753467

  Collaborator, Phase 2, Status unknown, 30 people, Sep 16, 2008

• NCT00501644

  Collaborator, Phase 2, Completed, 59 people, Jul 16, 2007

• NCT00207402

  Collaborator, Phase 4, Completed, 34 people, Sep 21, 2005

• NCT00148863

  Collaborator, Phase 2, Completed, 65 people, Sep 8, 2005

• Safety of Interferon Gamma-1b With Rituximab in Non-Hodgkin's Lymphoma Patients

  Phase 1/2, Terminated, 24 people, Apr 3, 2003

Sources: clinicaltrials.gov

• Functional ageing in fibrotic interstitial lung disease: the impact of frailty on adverse health outcomes

  Jan 23, 2020

• Severity and features of frailty in systemic sclerosis-associated interstitial lung disease

  May 25, 2017

Sources: api.crossref.org

• Telomere length associates with chronological age and mortality across racially diverse pulmonary fibrosis cohorts

  Consulting or advice, Fees or honoraria, Board or leadership role, Mar 17, 2023

• Impact of comorbidities and delay in diagnosis in elderly patients with pulmonary hypertension

  Fees or honoraria, Nov 28, 2018

Sources: pubmed.ncbi.nlm.nih.gov